Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis

[1]  Y. Kawaguchi,et al.  Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  T. Nishino,et al.  TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model. , 2004, Kidney international.

[3]  K. Wieczorowska-Tobis,et al.  Intraperitoneal enalapril ameliorates morphologic changes induced by hypertonic peritoneal dialysis solutions in rat peritoneum. , 2004, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[4]  T. Niwa,et al.  Role of advanced glycation end products and growth factors in peritoneal dysfunction in CAPD patients. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  Y. Kawaguchi,et al.  Association between an Increased Surface Area of Peritoneal Microvessels and a High Peritoneal Solute Transport Rate , 2003, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[6]  S. Teraoka,et al.  The ACE inhibitor, quinapril, ameliorates peritoneal fibrosis in an encapsulating peritoneal sclerosis model in mice. , 2002, Pharmacological research.

[7]  Y. Kawaguchi,et al.  [Long-standing high-transport membrane as a risk factor for EPS development after PD withdrawal: an analysis based on changes in peritoneal function during and after CAPD withdrawal]. , 2002, Nihon Jinzo Gakkai shi.

[8]  F. Akçiçek,et al.  By Reducing Production of Vascular Endothelial Growth Factor Octreotide Improves the Peritoneal Vascular Alterations Induced by Hypertonic Peritoneal Dialysis Solution , 2002, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[9]  O. Devuyst.  New insights in the molecular mechanisms regulating peritoneal permeability. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  Y. Asano,et al.  Changes in Peritoneal Coagulation and Fibrinolysis after Discontinuation of Chronic Peritoneal Dialysis , 2002, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[11]  Y. Kawaguchi,et al.  Risk factors and preventive measures for encapsulating peritoneal sclerosis--Jikei experience 2002. , 2002, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[12]  Y. Kawaguchi,et al.  High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment. , 2002, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[13]  T. Kawai,et al.  Preservation of peritoneal catheter for prevention of encapsulating peritoneal sclerosis. , 2002, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[14]  D. Struijk,et al.  Expression of Cancer Antigen 125 by Peritoneal Mesothelial Cells is Not Influenced by Duration of Peritoneal Dialysis , 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[15]  S. Mujais,et al.  Encapsulating Peritoneal Sclerosis: Definition, Etiology, Diagnosis, and Treatment , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[16]  Y. Kawaguchi,et al.  Longitudinal changes of peritoneal permeability after withdrawal from long-term CAPD treatment , 2000 .

[17]  O. Devuyst,et al.  Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. , 2000, Journal of the American Society of Nephrology : JASN.

[18]  S. Mujais,et al.  Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[19]  I. Pisoni,et al.  Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent? , 1999, Journal of nephrology.

[20]  K. Nitta,et al.  Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  C. Hawley,et al.  Sclerosing peritonitis: the experience in Australia. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  T. Shigematsu,et al.  Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. , 1997, Kidney international.

[23]  Y. Kawaguchi,et al.  Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  S. Komemushi,et al.  Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats. , 1995, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[25]  M. Ma,et al.  Immunosuppression in sclerosing peritonitis. , 1993, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[26]  M. Mcmillan,et al.  Immunosuppression in sclerosing peritonitis. , 1993, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[27]  W. Geis,et al.  Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. , 1980, Archives of internal medicine.